Partner for the AVF Fund (Animal Feed) and the Quadrivium Seed Fund at Seventure Partners · Joined 2013
View Live Interactive Profile →Philippe Tramoy is Partner for Seventure Partners' AVF Fund (animal feed) and the Quadrivium Seed Fund. His Seventure bio says he joined the firm in November 2013 as an investor in the Quadrivium 1 Seed Fund team, manages that fund's life sciences investments and reports to CEO Isabelle de Cremoux, and also serves as Investment Director for the AVF fund management team. He began his career in 2000 at Rhodia Corporate, Rhodia Chirex and Rhodia Pharma Solutions as Project Manager and Director of Business Development Europe, and in 2004 founded and managed CBDMT - Market & Business Intelligence. He holds an MSc in Biochemistry from the University of Burgundy, an MSc in Immunology and Genetics from the Ecole Normale Superieure de Lyon, a Master's in Finance from IAE Paris Pantheon-Sorbonne and a Master's in Intelligence Marketing from HEC Paris. His Seventure bio names Novobind, Proteon Pharmaceuticals, STRING BIO, Virovet and Animab among his portfolio companies. Seventure's French team page gives his title as "Directeur de participation pour le fonds AVF (animal feed) et le fonds d'amorcage Quadrivium", which is a level below the English "Partner"; the English title is used here and the discrepancy is recorded in the notes.